Classicare Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 27-06-2024
- Paid Up Capital ₹ 0.10 M
as on 27-06-2024
- Company Age 19 Year, 5 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 9.00 M
as on 27-06-2024
- Revenue 14.74%
(FY 2015)
- Profit 5.41%
(FY 2015)
- Ebitda 27.37%
(FY 2015)
- Net Worth 20.72%
(FY 2015)
- Total Assets 5.56%
(FY 2015)
About Classicare Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.00 M.
Minal Marathe and Uday Marathe serve as directors at the Company.
- CIN/LLPIN
U85195MH2005PTC153078
- Company No.
153078
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 May 2005
- Date of AGM
30 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Classicare Diagnostics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Minal Marathe  | Director | 06-May-2005 | Current |
| Uday Marathe | Director | 06-May-2005 | Current |
Financial Performance and Corporate Structure Insights of Classicare Diagnostics.
Classicare Diagnostics Private Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 14.74% increase. The company also saw a slight improvement in profitability, with a 5.41% increase in profit. The company's net worth Soared by an impressive increase of 20.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Classicare Diagnostics?
In 2015, Classicare Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Naava Wellness Private Limited
Active
12 years 5 months Minal Marathe and Uday Marathe are mutual person
Sanmita Medicare Private Limited
Active 14 years 9 months Minal Marathe and Uday Marathe are mutual person
Neelay Healthcare Private Limited
Active 16 years 3 months Minal Marathe and Uday Marathe are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 26 Jun 2015 | ₹7.00 M | Open |
Hdfc Bank Limited Creation Date: 09 Nov 2010 | ₹2.00 M | Open |
How Many Employees Work at Classicare Diagnostics?
Classicare Diagnostics has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Classicare Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Classicare Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
